EP2203432A4 - Method of treatment - Google Patents
Method of treatmentInfo
- Publication number
- EP2203432A4 EP2203432A4 EP08831660A EP08831660A EP2203432A4 EP 2203432 A4 EP2203432 A4 EP 2203432A4 EP 08831660 A EP08831660 A EP 08831660A EP 08831660 A EP08831660 A EP 08831660A EP 2203432 A4 EP2203432 A4 EP 2203432A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US97417507P | 2007-09-21 | 2007-09-21 | |
PCT/US2008/076519 WO2009039091A1 (en) | 2007-09-21 | 2008-09-16 | Method of treatment |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2203432A1 EP2203432A1 (en) | 2010-07-07 |
EP2203432A4 true EP2203432A4 (en) | 2011-04-27 |
Family
ID=40468285
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP08831660A Withdrawn EP2203432A4 (en) | 2007-09-21 | 2008-09-16 | Method of treatment |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP2203432A4 (en) |
WO (1) | WO2009039091A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113893252A (en) | 2016-03-11 | 2022-01-07 | 阿迪亚生命科学公司 | CXCR-2 inhibitors for the treatment of crystalline joint disorders |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004039775A2 (en) * | 2002-10-29 | 2004-05-13 | Smithkline Beecham Corporation | Il-8 receptor antagonists |
DE102005023834A1 (en) * | 2004-11-20 | 2006-05-24 | Bayer Healthcare Ag | Substituted [(phenylethanoyl) amino] benzamide |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UY25842A1 (en) * | 1998-12-16 | 2001-04-30 | Smithkline Beecham Corp | IL-8 RECEPTOR ANTAGONISTS |
US6653310B2 (en) * | 2000-04-07 | 2003-11-25 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
-
2008
- 2008-09-16 WO PCT/US2008/076519 patent/WO2009039091A1/en active Application Filing
- 2008-09-16 EP EP08831660A patent/EP2203432A4/en not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004039775A2 (en) * | 2002-10-29 | 2004-05-13 | Smithkline Beecham Corporation | Il-8 receptor antagonists |
DE102005023834A1 (en) * | 2004-11-20 | 2006-05-24 | Bayer Healthcare Ag | Substituted [(phenylethanoyl) amino] benzamide |
Non-Patent Citations (2)
Title |
---|
EIDELMAN O ET AL: "Cystic fibrosis and the use of pharmacogenomics to determine surrogate endpoints for drug discovery", AMERICAN JOURNAL OF PHARMACOGENOMICS, WOLTERS KLUWER HEALTH, XX, vol. 1, no. 3, 1 January 2001 (2001-01-01), pages 223 - 240, XP009146190, ISSN: 1175-2203 * |
See also references of WO2009039091A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP2203432A1 (en) | 2010-07-07 |
WO2009039091A1 (en) | 2009-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2032131A4 (en) | Method of treatment | |
IL208354A0 (en) | Methods of treatment | |
IL212348A0 (en) | Treatment method | |
EP2129369A4 (en) | Treatment of adhd | |
EP2174912A4 (en) | Method of treating copper-arsenic compound | |
GB0610746D0 (en) | Method of treatment | |
EP2350641A4 (en) | Method of treatment | |
ZA200901364B (en) | Method of treatment of photodermatoses | |
IL217492A0 (en) | Treatment method | |
VN25747A1 (en) | Method of water treatment | |
GB0718684D0 (en) | Treatment method | |
IL202002A0 (en) | Method of treating diabetes | |
EP2367544A4 (en) | Method of treatment of aggression | |
EP2194793A4 (en) | Method of treatment of fresh produce | |
EP2164494A4 (en) | Methods of treatment | |
GB0723100D0 (en) | Treatment of HFnEF | |
EP2203432A4 (en) | Method of treatment | |
GB0624439D0 (en) | Technique for treatment of gall-and kidney-stones | |
GB0717337D0 (en) | Method of treatment | |
GB0700969D0 (en) | Methods of treatment | |
GB0823435D0 (en) | Method of treatment | |
GB0618227D0 (en) | Novel method of treatment | |
GB0711228D0 (en) | Treatment method | |
ZA201102198B (en) | Treatment method | |
AU2007903139A0 (en) | Method of treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20100421 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA MK RS |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20110329 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20111026 |